1015061

Bahman Guyuron — FEI 3013298192

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 21, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lyndhurst, OH (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
722721 CFR 50.27(a)Consent form not approved/signed/dated
749821 CFR 312.66Unanticipated problems
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance